SCHEMBL13745197

SCHEMBL13745197

CCC(C)[C@H]1C(=O)N(Cc2cccc(F)c2)C[C@H]2N1C(=O)CN(Cc1ccccc1)N2C(=O)NCc1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CLPP Q16740 20/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13745200 0.93 CLPP (0.46) CLPP
SCHEMBL14619990 0.91 CLPP (0.55) CLPP
SCHEMBL14620166 0.90 CLPP (0.59) CLPP
SCHEMBL13184890 0.89 CLPP (0.56) CLPP
SCHEMBL14620317 0.89 CLPP (0.54) CLPP
SCHEMBL13184740 0.88 CLPP (0.56) CLPP
SCHEMBL12037738 0.87 CLPP (0.56) CLPP
SCHEMBL12037951 0.87 CLPP (0.48) CLPP
SCHEMBL13745195 0.87 CLPP (0.55) CLPP
SCHEMBL10224924 0.86 CLPP (0.51) CLPP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090215783-A1 COMPOSITION FOR INDUCTION OR INHIBITION OF STEM CELL DIFFERENTIATION CHOONGWAE PHARMA CORPORATION (KR) 2009-08-27 US disclosed
US-20090215783-A1 COMPOSITION FOR INDUCTION OR INHIBITION OF STEM CELL DIFFERENTIATION CHOONGWAE PHARMA CORPORATION (KR) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215783-A1 COMPOSITION FOR INDUCTION OR INHIBITION OF STEM CELL DIFFERENTIATION MYLK2, TNNC1, MYH2 CLPP 3986/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.